Derman R
J Reprod Med. 1986 Sep;31(9 Suppl):879-86.
Use of oral contraceptives has been shown to reduce the risk of gynecologic conditions that cause significant mortality, including ovarian cancer, endometrial cancer and ectopic pregnancy. Additionally, its use has been linked to quality-of-life issues, such as the prevention of pelvic inflammatory disease, benign breast disease and functional ovarian cysts, as well as to dysmenorrhea, premenstrual syndrome and iron deficiency anemia. Such information should be conveyed to women of reproductive age during their contraceptive counseling session.
已证明使用口服避孕药可降低导致重大死亡率的妇科疾病风险，包括卵巢癌、子宫内膜癌和异位妊娠。此外，其使用还与生活质量问题有关，如预防盆腔炎、良性乳腺疾病和功能性卵巢囊肿，以及痛经、经前综合征和缺铁性贫血。此类信息应在避孕咨询期间传达给育龄妇女。
